Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

234 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group.
Geyer JR, Sposto R, Jennings M, Boyett JM, Axtell RA, Breiger D, Broxson E, Donahue B, Finlay JL, Goldwein JW, Heier LA, Johnson D, Mazewski C, Miller DC, Packer R, Puccetti D, Radcliffe J, Tao ML, Shiminski-Maher T; Children's Cancer Group. Geyer JR, et al. Among authors: sposto r. J Clin Oncol. 2005 Oct 20;23(30):7621-31. doi: 10.1200/JCO.2005.09.095. J Clin Oncol. 2005. PMID: 16234523 Clinical Trial.
Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children's Cancer Group.
Jennings MT, Sposto R, Boyett JM, Vezina LG, Holmes E, Berger MS, Bruggers CS, Bruner JM, Chan KW, Dusenbery KE, Ettinger LJ, Fitz CR, Lafond D, Mandelbaum DE, Massey V, McGuire W, McNeely L, Moulton T, Pollack IF, Shen V. Jennings MT, et al. Among authors: sposto r. J Clin Oncol. 2002 Aug 15;20(16):3431-7. doi: 10.1200/JCO.2002.04.109. J Clin Oncol. 2002. PMID: 12177103 Clinical Trial.
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.
Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K; Children's Cancer Group. Nachman JB, et al. Among authors: sposto r. J Clin Oncol. 2002 Sep 15;20(18):3765-71. doi: 10.1200/JCO.2002.12.007. J Clin Oncol. 2002. PMID: 12228196 Clinical Trial.
A phase II study of preradiotherapy chemotherapy followed by hyperfractionated radiotherapy for newly diagnosed high-risk medulloblastoma/primitive neuroectodermal tumor: a report from the Children's Oncology Group (CCG 9931).
Allen J, Donahue B, Mehta M, Miller DC, Rorke LB, Jakacki R, Robertson P, Sposto R, Holmes E, Vezina G, Muraszko K, Puccetti D, Prados M, Chan KW. Allen J, et al. Among authors: sposto r. Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1006-11. doi: 10.1016/j.ijrobp.2008.09.019. Epub 2009 Apr 7. Int J Radiat Oncol Biol Phys. 2009. PMID: 19356859 Free PMC article. Clinical Trial.
Expression of p53 and prognosis in children with malignant gliomas.
Pollack IF, Finkelstein SD, Woods J, Burnham J, Holmes EJ, Hamilton RL, Yates AJ, Boyett JM, Finlay JL, Sposto R; Children's Cancer Group. Pollack IF, et al. Among authors: sposto r. N Engl J Med. 2002 Feb 7;346(6):420-7. doi: 10.1056/NEJMoa012224. N Engl J Med. 2002. PMID: 11832530 Free article.
Outcome for young children newly diagnosed with ependymoma, treated with intensive induction chemotherapy followed by myeloablative chemotherapy and autologous stem cell rescue.
Zacharoulis S, Levy A, Chi SN, Gardner S, Rosenblum M, Miller DC, Dunkel I, Diez B, Sposto R, Ji L, Asgharzadeh S, Hukin J, Belasco J, Dubowy R, Kellie S, Termuhlen A, Finlay J. Zacharoulis S, et al. Among authors: sposto r. Pediatr Blood Cancer. 2007 Jul;49(1):34-40. doi: 10.1002/pbc.20935. Pediatr Blood Cancer. 2007. PMID: 16874765
234 results